Ecstasy (MDMA) Rapid Test

Short Description:

The Genfocus® Ecstasy (MDMA) Rapid Test is a one step, lateral flow chromatographic immunoassay for the qualitative detection of MDMA and its metabolites in human urine. The test cut off is 500ng/ml. The rapid test provides only a preliminary test result. A more specific alternative chemical method, such as Gas Chromatography/Mass Spectrometry (GC/MS), must be used in order to obtain a confirmed analytical result. The National Institute on Drug Abuse (NIDA) has recommended GC/MS method as the preferred confirmation method.


Product Detail

Product Tags

Characteristics

212

The test boast of rapid and accurate diagnosis with the following characteristics:
Accuracy:
The accuracy of Genfocus® Ecstasy (MDMA) Rapid Test was evaluated in comparison to a commercially available one-step immunoassay. One hundred (100) urine samples collected from presumed non-user health people have been tested by both procedures with 100% agreement.
Reproducibility:
Of the fifty samples with MDMA concentration of 250ng/ml all were determined negative. Of the fifty samples with MDMA concentration of 1,000ng/ml all were determined positive.

Specifications

Item Value
Product name Ecstasy (MDMA) Rapid Test
Place of Origin Beijing, China
Brand Name JWF
Model Number **********
Power Source Manual
Warranty 2 years
After-sale Service Online technical support
Material Plastic, paper
Shelf Life 2 years
Quality Certification ISO9001, ISO13485
Instrument classification Class II
Safety standard None
Specimen Urine specimens.
Sample Available
Format Cassete
Certificate CE Approved
OEM Available
Package Cassette:1/ bag, Kit: 20tests/kit, package can be customized
Sensitivity /
Specificity /
Accuracy /

Packaging & delivery

Packaging: 1pc/box; 25pcs/box, 50 pcs/box, 100pcs/box, individual aluminium foil bag package for each piece product; OEM packing is available.

Port: any ports of China, optional.

Company Introduction

Beijing Jinwofu Bioengineering Technology Co., Ltd. focuses on high-quality in vitro diagnostic reagents. Through independent research and development, it has formed the core products of rapid in vitro diagnostic reagents with independent intellectual property rights: colloidal gold, latex rapid immune diagnostic reagent products, such as infectious disease detection series, eugenics and eugenics detection series, infectious disease detection products, etc.
Welcome to contact us for more information!


  • Previous:
  • Next: